Highlights Granules India Limited

Equities

GRANULES

INE101D01020

Market Closed - Bombay S.E. Other stock markets 03:00:38 2024-05-18 am EDT			5-day change	1st Jan Change
406.6 ^INR	+1.21%		+0.40%	+0.31%

May. 15	Transcript : Granules India Limited, Q4 2024 Earnings Call, May 15, 2024
May. 15	Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion	RE

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Granules India Posts Decline in Fiscal Q4 Consolidated Net Profit, Revenue	May. 15	MT
Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion	May. 15	RE
Granules India Limited Recommends Final Dividend for the Financial Year 2023-24, Payable on July 30, 2024	May. 15	CI
Granules India Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 15	CI
Granules India Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 15	CI
Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit	Apr. 15	MT
Granules India Unit Gets VAI Status for Virginia Facility	Apr. 03	MT
Paracetamol maker Granules India posts marginal rise in Q3 profit	Jan. 23	RE
Granules India's Posts Gains in Fiscal Q3 Consolidated Net Profit	Jan. 23	MT
Granules India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 23	CI
Granules Pharmaceuticals Unit's Virginia Facility Gets Five Observations from US FDA	Dec. 18	MT
Granules India Gets US FDA Nod for Pantoprazole Sodium Delayed-Release Tablets	Dec. 13	MT
Granules India Limited Receives ANDA Approval for Pantoprazole Sodium Delayed-Release Tablets	Dec. 13	CI
Granules India Arm Gets US FDA Nod for Sildenafil for Oral Suspension	Dec. 03	MT
Paracetamol maker Granules India's Q2 revenue rises on higher N.America demand	Nov. 09	RE
Granules India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 09	CI
Granules India Limited Receives ANDA Approval for Esomeprazole Magnesium Delayed-Release Capsules	23-10-19	CI
Indian paracetamol maker Valiant Laboratories lists at 16% premium	23-10-06	RE
Granules India Gets US FDA Nod for Hypertension Treatment Drug	23-10-01	MT
Granules India Limited Announces the US Food & Drug Administration Approval of its Abbreviated New Drug Application for Losartan Potassium and Hydrochlorothiazide Tablets USP	23-09-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Granules India Limited

Equities

GRANULES

INE101D01020

Highlights

Filters